Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis-like lung disease in mice. [electronic resource]
Producer: 20180713Description: 671-680 p. digitalISSN:- 1873-5010
- Administration, Inhalation
- Animals
- Cystic Fibrosis -- metabolism
- Disease Models, Animal
- Epithelial Sodium Channel Blockers -- pharmacology
- Epithelial Sodium Channels -- metabolism
- Mice
- Oligonucleotides, Antisense -- pharmacology
- Respiratory Mucosa -- metabolism
- Respiratory System Agents -- pharmacology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.